Concepedia

Friedrich Scheiflinger

FS

Statistics

Publications

31

Citations

2.5K

H-Index

20

Active since

1992

Affiliations

Baxter (Austria)(Current)

Takeda (Austria)

University Hospital of Bern

University of Washington

TU Wien

Friedrich Scheiflinger is an author at Baxter (Austria) specializing in hematology, medicine, and life sciences.

ORCID

Publications per year

1992–2023

31

Publications

31

Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity

Silvia Ferrari, Friedrich Scheiflinger, Manfred Rieger et al. · Blood · 2006 · 294 citations · Full text

, , +7

Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)

Barbara Plaimauer, Klaus F. Zimmermann, Dirk Völkel et al. · Blood · 2002 · 229 citations

, , +9

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

Barbara A. Konkle, Christopher Walsh, Miguel A. Escobar et al. · Blood · 2020 · 188 citations · Full text

, , +5

ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice

Frederik Denorme, Friederike Langhauser, Linda Desender et al. · Blood · 2016 · 183 citations · Full text

, , +15

Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors

Anita Kruzik, Damir Fetahagic, Bettina Hartlieb et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 177 citations · Full text

, , +13

1–5 of 31